Status:
UNKNOWN
Post-Cardiotomy Extra-Corporeal Life Support Study
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Cardiogenic Shock
Resuscitation
Eligibility:
All Genders
18-99 years
Brief Summary
Extracorporeal life support is increasingly used after cardiac surgery. Despite improved technology, outcome still remains poor. This retrospective multicenter cohort study aims to find the (risk) fa...
Detailed Description
The prevalence of post-cardiotomy extracorporeal life support (PC-ECLS) reported in the literature varies between 0.6% and 3.6% of all cardiac surgical cases and has represented the most frequent indi...
Eligibility Criteria
Inclusion
- Cardiac surgery prior to Extracorporeal Life Support (ECLS: VA-ECMO, VV-ECMO, ECCOR2) / Extracorporeal Membrane Oxygenation (ECMO);
- Patients who received treatment (cardiac surgery AND adjuvant ECLS) between January 2000 and December 2018
Exclusion
- Extra-corporeal life support (ECLS) in patients who had cardiac surgery procedures, but with implant not strictly related to surgery-related hospitalization;
- ECMO implant after discharge will not be considered.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03857217
Start Date
March 1 2019
End Date
September 1 2019
Last Update
February 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Centre
Maastricht, Netherlands